Consun Pharmaceutical Group Limited (stock code: 01681) reported no change to its authorized share capital for October 2025, remaining at 5,000,000,000 ordinary shares at HKD 0.1 each, totaling HKD 500,000,000.

The issued share capital (excluding treasury shares) increased by 34,100 shares during the reporting period, bringing the total issued shares to 847,973,407 as of month-end. This adjustment resulted from the exercise of options under the share option scheme approved on December 2, 2013, raising approximately HKD 143,078.6.

Information shows 3,000,000 shares had been repurchased on May 22, 2025, but were not yet cancelled as of the end of October 2025. No changes occurred in treasury shares during the month under review.